ScripEurope’s largest privately held biotech, BioNTech SE , is adding to its clinical-stage product pipeline through the acquisition of antibody assets and US infrastructure from San Diego, CA-based MabV
ScripTrading of Opko Health Inc. shares on Nasdaq was halted by the exchange on Sept. 7 and the company said on Sept. 11 that trading will not resume until the company provides a satisfactory response to
ScripScrip regularly covers business development and deal-making in the biopharmaceutical industry. Below is a roundup of some of the most noteworthy recent transactions. Deal Watch is supported by deal in
ScripEli Lilly & Co. said on May 14 that it will pay $110m up front to buy AurKa Pharma Inc. in a deal that will bring the Aurora kinase inhibitor AK-01 back home to Lilly, which licensed the molecule t